Abstract:Healthcare is undergoing a transformation, and it is imperative to leverage new technologies to generate new data and support the advent of precision medicine (PM). Recent scientific breakthroughs and technological advancements have improved our understanding of disease pathogenesis and changed the way we diagnose and treat disease leading to more precise, predictable and powerful health care that is customized for the individual patient. Genetic, genomics, and epigenetic alterations appear to be contributing to different diseases. Deep clinical phenotyping, combined with advanced molecular phenotypic profiling, enables the construction of causal network models in which a genomic region is proposed to influence the levels of transcripts, proteins, and metabolites. Phenotypic analysis bears great importance to elucidat the pathophysiology of networks at the molecular and cellular level. Digital biomarkers (BMs) can have several applications beyond clinical trials in diagnostics—to identify patients affected by a disease or to guide treatment. Digital BMs present a big opportunity to measure clinical endpoints in a remote, objective and unbiased manner. However, the use of "omics" technologies and large sample sizes have generated massive amounts of data sets, and their analyses have become a major bottleneck requiring sophisticated computational and statistical methods. With the wealth of information for different diseases and its link to intrinsic biology, the challenge is now to turn the multi-parametric taxonomic classification of a disease into better clinical decision-making by more precisely defining a disease. As a result, the big data revolution has provided an opportunity to apply artificial intelligence (AI) and machine learning algorithms to this vast data set. The advancements in digital health opportunities have also arisen numerous questions and concerns on the future of healthcare practices in particular with what regards the reliability of AI diagnostic tools, the impact on clinical practice and vulnerability of algorithms. AI, machine learning algorithms, computational biology, and digital BMs will offer an opportunity to translate new data into actionable information thus, allowing earlier diagnosis and precise treatment options. A better understanding and cohesiveness of the different components of the knowledge network is a must to fully exploit the potential of it.

Precision Medicine as an Accelerator for Next Generation Cognitive Supercomputing

Precision Medicine, AI, and the Future of Personalized Health Care

Artificial Intelligence, Physiological Genomics, and Precision Medicine.

Are innovation and new technologies in precision medicine paving a new era in patients centric care?

Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis

Optimizing Clinical Workflow Using Precision Medicine and Advanced Data Analytics

AI Meets Exascale Computing: Advancing Cancer Research With Large-Scale High Performance Computing

Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis

Accelerating Scientific Computing in the Post-Moore’s Era

Convergence of Artificial Intelligence and High Performance Computing on NSF-supported Cyberinfrastructure

Current Status and Future Directions: The Application of Artificial Intelligence/Machine Learning for Precision Medicine

High-performance medicine: the convergence of human and artificial intelligence

Problems, challenges and promises: perspectives on precision medicine

Convergence of Precision Medicine and Public Health Into Precision Public Health: Toward a Big Data Perspective

Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine

Achieving Inclusive Healthcare through Integrating Education and Research with AI and Personalized Curricula

Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?

Panomics for Precision Medicine

Big Data – Driving a Revolution in Personalized Medicine

A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine

Toward multiomics-based next-generation diagnostics for precision medicine